Skip Navigation
Explore our COVID-19 Resources and Updates
CHS blue logo square
Home > Our Work > All Publications > 2014


Our publications keep professionals working across the public, private, and academic sectors informed on the most important developments and issues in health security and biosecurity.

Find an article or report by keywords:

Find an article or report or see all by area, author, or year:


Singapore-US Strategic Dialogue on Biosecurity, July 2014

Gigi Kwik Gronvall, Sanjana Ravi, Ryan Morhard, Anita Cicero, Tom Inglesby
Date posted:
July 01, 2014
Publication type:
This publication results from research supported by the Naval Postgraduate School’s Project on Advanced Systems and Concepts for Countering Weapons of Mass Destruction (PASCC) via Assistance Grant/Agreement No. N00244-14-1-0040 awarded by the NAVSUP Fleet Logistics Center San Diego (NAVSUP FLC San Diego).
See also:
Singapore is poised to be a critical partner to the US in minimizing biosecurity challenges in Southeast Asia. As a nation, it is vulnerable to both emerging infectious disease and potential terrorism in the region. In addition to its geographical importance within the Asia-Pacific region, Singapore is a rising powerhouse in biotechnology, having invested $13.2B in biotech R&D from 2011-2015. As a result, it has become an attractive site for international biotechnology companies like Novartis, as well as world-class research universities. It is home to government and academic expertise capable of identifying and responding to biosecurity challenges. Its expertise is, in many ways, complementary to that of the US in these realms. 



Our Mission

To protect people’s health from epidemics and disasters and ensure that communities are resilient to major challenges.